Hailing from The Motor City of Detroit, Michigan, Eric P. Lefkofsky is a popular and leading innovator and IT guru. Sitting on top of a giant fortune that he has amassed over the course of his career, Lefkofsky is listed on the Forbes prestigious billionaires list. He has started or been a part of a long list of successful companies such as Mediaocean, InnerWorkings, Lightbank, and more.
Due to personal reasons dear to his heart and his overall philanthropic spirit, Eric Lefkofsky decided to leave the pure business realm and enter into life-saving biotechnology. He recently created a new biotechnology company called Tempus. Tempus is currently spearheading ways to vastly improve cancer diagnosis. Through innovative ideas and strategies, Eric has already lead Tempus to the forefront of early cancer detection.
Experts within the biotechnology industry and referring to Tempus as an end-to-end service that helps hospitals and health institutes work together to maximize common goals more efficiently. Tempus is currently building a groundbreaking data set that once fully realized will provide a huge step forward in the fight against cancer. The data set seeks to harness a massive amount of patient-driven data and run it through an algorithm that is able to read gene sequences. The algorithm reads data from thousands of patients and analyzes their genes, thus formulating much better detection protocols against the particular genetic profiles that are at a much higher risk for certain types of cancers.
Where Tempus will generate revenue is by offering select patients their gene-sequencings analysis. In partnership with the cooperation known as Northwestern clinic, Tempus will provide their software in exchange for as much patient data as Northwestern is able to provide. With this data, Tempus will continue to grow their already massive data set to further increase the accuracy of their cancer screening system. The more data Tempus has the more accurate their software will become at early cancer detection.
Many biotechnology experts have noticed that the activities of Tempus and Lefkofsky’s role within the company have largely remained a secret. Is thought that due to the philanthropic aspect of the company that Eric likely wants to pull as much attention away from himself and instead cast the brightest light he can on the battle against cancer itself.